Višnja Škerk

640 total citations
38 papers, 415 citations indexed

About

Višnja Škerk is a scholar working on Epidemiology, Urology and Microbiology. According to data from OpenAlex, Višnja Škerk has authored 38 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 17 papers in Urology and 12 papers in Microbiology. Recurrent topics in Višnja Škerk's work include Urinary Tract Infections Management (17 papers), Urinary Bladder and Prostate Research (17 papers) and Reproductive tract infections research (10 papers). Višnja Škerk is often cited by papers focused on Urinary Tract Infections Management (17 papers), Urinary Bladder and Prostate Research (17 papers) and Reproductive tract infections research (10 papers). Višnja Škerk collaborates with scholars based in Croatia, Italy and Germany. Višnja Škerk's co-authors include S Schönwald, Ivan Krhen, Leo Markovinović, Alemka Markotić, Srđan Roglić, Adriana Vince, Gianpaolo Perletti, Josip Čulig, Emanuela Marras and Kurt G. Naber and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Antimicrobial Agents and European Journal of Clinical Microbiology & Infectious Diseases.

In The Last Decade

Višnja Škerk

33 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Višnja Škerk Croatia 11 226 132 130 76 60 38 415
S Schönwald Croatia 12 337 1.5× 131 1.0× 80 0.6× 77 1.0× 40 0.7× 25 507
Staffan Seeberg Sweden 15 199 0.9× 111 0.8× 41 0.3× 88 1.2× 138 2.3× 37 522
Endre Ludwig Hungary 11 243 1.1× 36 0.3× 42 0.3× 35 0.5× 24 0.4× 34 403
W Huck United States 10 252 1.1× 39 0.3× 72 0.6× 34 0.4× 34 0.6× 13 372
Ioannis Katsarolis Greece 11 213 0.9× 69 0.5× 18 0.1× 50 0.7× 58 1.0× 25 436
J. Richards United Kingdom 8 135 0.6× 32 0.2× 28 0.2× 63 0.8× 32 0.5× 13 422
Marie J. Gribble Canada 12 177 0.8× 22 0.2× 91 0.7× 25 0.3× 35 0.6× 19 405
Joshua R. Watson United States 10 200 0.9× 21 0.2× 65 0.5× 26 0.3× 45 0.8× 30 361
Frederick J. Buckwold Canada 9 137 0.6× 76 0.6× 34 0.3× 16 0.2× 100 1.7× 10 358
LE Nicolle Canada 8 284 1.3× 15 0.1× 92 0.7× 22 0.3× 32 0.5× 28 402

Countries citing papers authored by Višnja Škerk

Since Specialization
Citations

This map shows the geographic impact of Višnja Škerk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Višnja Škerk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Višnja Škerk more than expected).

Fields of papers citing papers by Višnja Škerk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Višnja Škerk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Višnja Škerk. The network helps show where Višnja Škerk may publish in the future.

Co-authorship network of co-authors of Višnja Škerk

This figure shows the co-authorship network connecting the top 25 collaborators of Višnja Škerk. A scholar is included among the top collaborators of Višnja Škerk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Višnja Škerk. Višnja Škerk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Škerk, Višnja, Ognjen Kraus, Jasmina Vraneš, et al.. (2017). ISKRA GUIDELINES ON DIAGNOSTICS AND TREATMENT OF PROSTATITIS – CROATIAN NATIONAL GUIDELINES. Dr Med - University of Zagreb School of Medicine Digital Repository. 139. 0–0. 1 indexed citations
2.
Meštrović, Tomislav, Sunčanica Ljubin-Šternak, Mario Sviben, et al.. (2016). Antimicrobial Sensitivity Profile of Chlamydia trachomatis isolates from Croatia in McCoy Cell Culture System and Comparison with the Literature. Clinical Laboratory. 62(03/2016). 357–64. 7 indexed citations
3.
Škerk, Višnja, et al.. (2015). Platelet satellitism in infectious disease?. Biochemia Medica. 25(2). 285–294. 7 indexed citations
4.
Kotarski, Viktor, Alemka Markotić, Arjana Tambić Andrašević, et al.. (2014). The significance ofChlamydia trachomatisin prostatitis syndrome. Journal of Chemotherapy. 26(6). 382–384. 4 indexed citations
5.
Šoprek, Silvija, Miša Korva, Boris Dželalija, et al.. (2012). Serum levels of metalloproteinases and their inhibitors during infection with pathogens having integrin receptor-mediated cellular entry. Scandinavian Journal of Infectious Diseases. 44(9). 663–669. 5 indexed citations
6.
Ljubin-Šternak, Sunčanica, Tomislav Meštrović, Tatjana Vilibić‐Čavlek, et al.. (2012). In vitro susceptibility of urogenital Chlamydia trachomatis strains in a country with high azithromycin consumption rate. Folia Microbiologica. 58(5). 361–365. 18 indexed citations
7.
Magri, Vittorio, E. Montanari, Višnja Škerk, et al.. (2011). Fluoroquinolone–macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction. Asian Journal of Andrology. 13(6). 819–827. 38 indexed citations
8.
Sternak, Sunčanica Ljubin & Višnja Škerk. (2010). Determining antimicrobial resistance to Chlamydia trachomatis and applying present findings in daily practice. SHILAP Revista de lepidopterología. 1 indexed citations
9.
Škerk, Višnja, et al.. (2010). Ispitivanje djelotvornosti profilaktičke primjene probiotika Acidosalus® u žena s rekurentnim cistitisom. University of Zagreb University Computing Centre (SRCE). 30(1). 21–25. 1 indexed citations
10.
Škerk, Višnja, et al.. (2009). The Significance of Chlamydia trachomatisin Urethritis and Prostatitis – Differences in Therapeutic Approach – Croatian Experience. Journal of Chemotherapy. 21(1). 63–67. 6 indexed citations
11.
Markotić, Alemka, et al.. (2009). Is the clinical picture of Schnitzler syndrome always Schnitzler syndrome?. PubMed. 27(3). 507–9. 4 indexed citations
12.
13.
Škerk, Višnja, et al.. (2006). Postmarketing research of the efficacy and tolerability of fluconazole and clotrimazole in the treatment of vulvovaginal Candidiasis. 26(3). 135–137. 1 indexed citations
14.
Škerk, Višnja, et al.. (2006). Bakterijske spolno prenosive bolesti kao čimbenik u nastanku raka vrata maternice: suvremeni terapijski pristupi. University of Zagreb University Computing Centre (SRCE). 15. 309–316.
15.
Škerk, Višnja, et al.. (2004). Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis. International Journal of Antimicrobial Agents. 24(2). 188–191. 22 indexed citations
16.
Škerk, Višnja, S Schönwald, Ivan Krhen, et al.. (2002). Comparative Analysis of Azithromycin and Clarithromycin Efficacy and Tolerability in the Treatment of Chronic Prostatitis Caused byChlamydia trachomatis. Journal of Chemotherapy. 14(4). 384–389. 13 indexed citations
17.
Škerk, Višnja, et al.. (2002). Aetiology of chronic prostatitis. International Journal of Antimicrobial Agents. 19(6). 471–474. 53 indexed citations
18.
Tambić-Andrašević, Arjana, et al.. (2001). Antibiotic resistance among urinary tract pathogens. 17.
19.
Schönwald, S, et al.. (1999). Azithromycin: Single 1.5g dose in the treatment of patients with atypical pneumonia syndrome—A randomized study. Infection. 27(3). 198–202. 44 indexed citations
20.
Schönwald, S, et al.. (1991). Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia. European Journal of Clinical Microbiology & Infectious Diseases. 10(10). 877–880. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Schönwald Breakdown of academic impact, for papers by Staffan Seeberg Breakdown of academic impact, for papers by Endre Ludwig Breakdown of academic impact, for papers by W Huck Breakdown of academic impact, for papers by Ioannis Katsarolis Breakdown of academic impact, for papers by J. Richards Breakdown of academic impact, for papers by Marie J. Gribble Breakdown of academic impact, for papers by Joshua R. Watson Breakdown of academic impact, for papers by Frederick J. Buckwold Breakdown of academic impact, for papers by LE Nicolle
Rankless by CCL
2026